To increase visibility and form possible unions, Conscious Capital® connects impactful companies with family offices and institutional investors, key opinion leaders and government officials.

Our comprehensive and customized roadshows provide insights into operating throughout Asia, as well as the opportunity to explore potential investment and cross-border partnering opportunities.

Our roadshows in China provide insights into operating throughout China and fortifying U.S.and China relations, and the opportunity for potential investment and cross-border partnering opportunities.

Japan is one of the world’s most developed and sophisticated healthcare markets, especially in the biopharmaceutical and medical technology space.

Japan not only has a complex and potentially rewarding reimbursement model for marketed products, but also has a vibrant R&D landscape with innovative incentives.

In areas such as Regenerative Medicine, for example, Japan is a global leader, having implemented a unique regulatory mechanism for the expedited approval of Regenerative Medicines.

With a rapidly-aging population, Japan can present opportunities for innovative companies to expand internationally.

Disclaimer:   Conscious Capital AG, Conscious Capital, Inc., and Conscious Giving, Inc. (collectively referred to hereinafter as “Conscious Capital”) are legally independent entities. Conscious Capital and its affiliates, and their respective employees, officers and directors take no part in the negotiation or execution of transactions for the purchase or sale of securities. This website is not to be used or considered as, does not constitute or form part of, an offer to or solicitation of an offer to sell, purchase, exchange or transfer any securities or invitation to subscribe for any securities in any jurisdiction, and does not constitute an advertisement of securities in any other jurisdiction. Use of this website is not for any person or entity that is a citizen or resident or located in any locality, state, country, or other jurisdiction in which such use would be contrary to law or regulation, or which would require any registration or licensing within such jurisdiction, including, but not limited to, the United States, Canada, Australia, the United Kingdom, or Japan. For additional disclaimers, please click here